Taken together, our experiments suggest that the large VEGF165 isoform, through binding to VEGFR-2 and NRP1, directly affects the contractile properties of cardiomyocytes, thereby initiating LV dilatation and cardiac disease. Here, NRP1 is linked to heart disorder.